Literature DB >> 6337344

Detection of hepatitis B surface antigen using time-resolved fluoroimmunoassay.

H Siitari, I Hemmilä, E Soini, T Lövgren, V Koistinen.   

Abstract

Conventional fluoroimmunoassay (FIA) methods based on various fluorescence principles have not achieved the sensitivity of radioimmunoassay (RIA) mainly because of problems of background fluorescence arising, for example, from the biological specimen. We now describe an immunoassay of hepatitis B surface antigen (HBsAg) based on time-resolved (TR) fluorescence using a lanthanide as label. The assay initiates the development of a new generation of immunoassays. The fluorescence intensity is measured after a selected delay time which almost completely eliminates background fluorescence, which has a fast decay time. The excitation is performed with a flashing light source. The molecules with a long fluorescent lifetime consist of chelates of rare earth metals (Eu, Tb, Sm, Dy). They absorb strongly the excitation radiation and transfer the energy to the chelated central atom which in turn produces an emission spectrum characteristic of the lanthanide used. A long Stokes' shift (greater than 270 nm) helps to reduce the background in the emission region of the chelate and thus optimizes measurement of the relevant fluorescence. The present TR-FIA uses 2-naphthoyltrifluoroacetone as chelating agent because it creates an intense fluorescence with the rare earth metals. Synergistic agents such as trioctylphosphineoxid further enhance the fluorescence of the chelate. Depending on the instrumentation used for measuring time-resolved fluorescence and the conditions used for chelate formation, lanthanides can be detected at 10(-12)-10(-14)M concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337344     DOI: 10.1038/301258a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

1.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Photochemical characterization of up-converting inorganic lanthanide phosphors as potential labels.

Authors:  Tero Soukka; Katri Kuningas; Terhi Rantanen; Ville Haaslahti; Timo Lövgren
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

3.  Assessment of urinary total testosterone production by a highly sensitive time-resolved fluorescence immunoassay.

Authors:  Shihua Bao; Yifeng Peng; Shile Sheng; Qide Lin
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Time-resolved fluoroimmunoassay compared with virus isolation for rapid detection of respiratory syncytial virus in nasopharyngeal aspirates.

Authors:  M Waris; P Halonen; T Ziegler; S Nikkari; G Obert
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

Review 5.  Lanthanide complex-based fluorescence label for time-resolved fluorescence bioassay.

Authors:  Jingli Yuan; Guilan Wang
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

6.  Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay.

Authors:  Owen Kavanagh; Mary K Estes; Amanda Reeck; Ravikiran M Raju; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

7.  Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry.

Authors:  P Shankaran; E Reichstein; M J Khosravi; E P Diamandis
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

8.  Detection of tetanus antitoxin using Eu(3+)-labeled anti-human immunoglobulin G monoclonal antibodies in a time-resolved fluorescence immunoassay.

Authors:  J P Schröder; W D Kuhlmann
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.

Authors:  Shi Le Sheng; Qing Wang; Gang Huang; Bin Yu; Wen Xin Qin
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours.

Authors:  S L Sheng; S H Bao; G Huang; L M Wang
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.